Lufei Zhang

1.2k total citations
33 papers, 905 citations indexed

About

Lufei Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lufei Zhang has authored 33 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Lufei Zhang's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (4 papers). Lufei Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (4 papers). Lufei Zhang collaborates with scholars based in China, United Kingdom and Madagascar. Lufei Zhang's co-authors include Weilin Wang, Dongkai Zhou, Xiaohu Zhou, Yohei Ohashi, Roger Williams, Haiyang Xie, Nicholas T. Ktistakis, John E. Burke, Glenn R. Masson and Nicolas Soler and has published in prestigious journals such as Science, PLoS ONE and Cancer Letters.

In The Last Decade

Lufei Zhang

30 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lufei Zhang China 16 465 281 220 212 161 33 905
H. Zhong United States 14 278 0.6× 121 0.4× 101 0.5× 198 0.9× 66 0.4× 32 630
Xingyu Wu China 19 493 1.1× 213 0.8× 164 0.7× 76 0.4× 66 0.4× 67 953
Christhunesa S. Christudass United States 13 422 0.9× 103 0.4× 104 0.5× 314 1.5× 26 0.2× 28 795
Nadine S. Jahchan United States 15 861 1.9× 203 0.7× 656 3.0× 276 1.3× 62 0.4× 29 1.5k
Andrea Degasperi United Kingdom 13 746 1.6× 496 1.8× 234 1.1× 54 0.3× 57 0.4× 21 1.3k
Mairene Coto‐Llerena Switzerland 16 608 1.3× 436 1.6× 243 1.1× 240 1.1× 89 0.6× 39 1.3k
Sahil Chopra United States 8 264 0.6× 155 0.6× 183 0.8× 167 0.8× 52 0.3× 11 809
Dingyuan Hu China 17 340 0.7× 150 0.5× 269 1.2× 67 0.3× 79 0.5× 52 704
Zihao Qi China 19 516 1.1× 272 1.0× 304 1.4× 100 0.5× 49 0.3× 37 928
Xi Rao China 21 908 2.0× 511 1.8× 181 0.8× 55 0.3× 78 0.5× 56 1.4k

Countries citing papers authored by Lufei Zhang

Since Specialization
Citations

This map shows the geographic impact of Lufei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lufei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lufei Zhang more than expected).

Fields of papers citing papers by Lufei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lufei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lufei Zhang. The network helps show where Lufei Zhang may publish in the future.

Co-authorship network of co-authors of Lufei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lufei Zhang. A scholar is included among the top collaborators of Lufei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lufei Zhang. Lufei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lufei, Yuan Ge, Zhi‐Hong Guan, Gang Ye, & Haoyu Feng. (2024). Path planning of underwater vehicle based on improved particle swarm algorithm. 5584–5589. 2 indexed citations
4.
Zhang, Qiyi, Xingyu Liu, Shumei Wei, et al.. (2021). Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study. Frontiers in Oncology. 11. 751391–751391. 55 indexed citations
5.
Huang, Yu, Wenhao Ge, Yuan Ding, et al.. (2021). The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate hepatocellular carcinoma progression by regulating cyclin-dependent kinase 1 expression. Cancer Cell International. 21(1). 636–636. 9 indexed citations
6.
Zhang, Yuan, Lufei Zhang, Yucheng Xiang, et al.. (2020). Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis. Cancer Research and Treatment. 53(1). 184–198. 17 indexed citations
7.
Long, Bo, et al.. (2020). Model Predictive Control for Dual-Active-Bridge Converters in Stability Maintenance and Control of Power Transmission System. IECON 2020 The 46th Annual Conference of the IEEE Industrial Electronics Society. 36. 3242–3247. 1 indexed citations
8.
Zhang, Lufei, et al.. (2020). Do Elderly Patients With Stage I–II Hepatocellular Carcinoma Benefit From More Radical Surgeries? A Population-Based Analysis. Frontiers in Oncology. 10. 479–479. 4 indexed citations
9.
Zhu, Xiaowei, Bowen Yu, Wei Xue, et al.. (2018). ShenTu: Processing Multi-Trillion Edge Graphs on Millions of Cores in Seconds. 706–716. 42 indexed citations
10.
Kong, Yang, Lufei Zhang, Yu Huang, et al.. (2017). Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway. Cancer Letters. 407. 76–83. 54 indexed citations
11.
Chen, Dong, Lufei Zhang, Xiaohu Zhou, et al.. (2017). The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer. Oncotarget. 8(41). 70642–70652. 47 indexed citations
12.
Zhang, Lufei, Yuan Zhang, Tianyu He, et al.. (2017). The downregulation of NCRUPAR is associated with the clinical characteristics of hepatocellular carcinoma. Translational Cancer Research. 6(2). 402–408. 1 indexed citations
13.
Chen, Linghui, Qiang Sun, Dongkai Zhou, et al.. (2017). HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer. Cancer Letters. 411. 106–116. 58 indexed citations
14.
He, Tianyu, Lufei Zhang, Yang Kong, et al.. (2017). Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis. International Journal of Oncology. 51(6). 1722–1730. 46 indexed citations
15.
Zhang, Lufei, et al.. (2016). Modal Analysis of Iced Conductor Galloping for Continuous Spans. 28(11). 2654. 1 indexed citations
16.
Zhang, Lufei, Tianyu He, Yingcai Yan, et al.. (2016). Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma. BioMed Research International. 2016. 1–5. 13 indexed citations
19.
Wang, Weilin, Pengfei Huang, Lufei Zhang, et al.. (2013). Antitumor efficacy of CXC motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo. Cancer Science. 104(11). 1523–1531. 42 indexed citations
20.
Chen, Zuoning, et al.. (2011). vStarCloud: A New Network Computing Operating System for Multicore and Clouds. 3. 265–271. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026